{"content":"<li class=\"n-box-item date-title\" data-end=\"1364270399\" data-start=\"1364184000\" data-txt=\"Friday, December 20, 2019\">Monday, March 25, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"908881\" data-ts=\"1364254362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VCTL\" target=\"_blank\">VCTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rainmaker Systems (RMKR) announces plans to offer up to $7.2M of shares of its common stock. The...</a></h4><p>Rainmaker Systems (RMKR) announces plans to offer up to $7.2M of shares of its common stock. The Company intends to use the net proceeds for general corporate purposes, including working capital and capital expenditures. The offering is to market conditions, and the actual size or terms have not yet been determined. Shares <font color=\"red\">-3.8%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"908881\" data-linked=\"Rainmaker Systems (RMKR) announces plans to offer up to $7.2M of shares of its common stock. The...\" data-tweet=\"$VCTL - Rainmaker Systems (RMKR) announces plans to offer up to $7.2M of shares of its common stock. The Company intends to use the net proceeds for general corporate purposes, including working capital and capital expenditures. The offering is to marke... https://seekingalpha.com/news/908881?source=tweet\" data-url=\"https://seekingalpha.com/news/908881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908811\" data-ts=\"1364250272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMAN\" target=\"_blank\">GMAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908811\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Gordmans Stores (NASDAQ:GMAN): Q4 beats on its EPS but comes up shore on revenue. Net...</a></h4>More on Gordmans Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/GMAN' title='Gordmans Stores'>GMAN</a>): <a href=\"https://seekingalpha.com/market_currents/post/908381\" target=\"_blank\">Q4 beats</a> on its EPS but comes up shore on revenue. Net earnings fell 22% Y/Y as the discount retailer reported higher costs and expenses. Gross margin narrowed to 38.7% from 40.1%, as input costs increased 12%. SG&amp;A expenses also grew 13% to $65.6M. Shares -55 AH.<div class=\"tiny-share-widget\" data-id=\"908811\" data-linked=\"More on Gordmans Stores (NASDAQ:GMAN): Q4 beats on its EPS but comes up shore on revenue. Net...\" data-tweet=\"$GMAN $GMAN-OLD - More on Gordmans Stores (NASDAQ:GMAN): Q4 beats on its EPS but comes up shore on revenue. Net earnings fell 22% Y/Y as the discount retailer reported higher costs and expenses. Gross margin narrowed to 38.7% from 40.1%, as input costs ... https://seekingalpha.com/news/908811?source=tweet\" data-url=\"https://seekingalpha.com/news/908811\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908781\" data-ts=\"1364249322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFOP\" target=\"_blank\">AFOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908781\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance Fiber Optic (NASDAQ:AFOP) lifts its sales guidance for Q1, citing...</a></h4><p>Alliance Fiber Optic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AFOP\" title=\"Alliance Fiber Optic Products, Inc.\">AFOP</a>) lifts its sales guidance for Q1, citing stronger-than-expected demand across several lines and market segments. The fiber-optic component supplier now expects to report sales of  $12M, above earlier projections of $11.6M made in January. The company will release its Q1 results next month. Shares <font color=\"green\">+3%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"908781\" data-linked=\"Alliance Fiber Optic (NASDAQ:AFOP) lifts its sales guidance for Q1, citing...\" data-tweet=\"$AFOP - Alliance Fiber Optic (NASDAQ:AFOP) lifts its sales guidance for Q1, citing stronger-than-expected demand across several lines and market segments. The fiber-optic component supplier now expects to report sales of $12M, above earlier projections ... https://seekingalpha.com/news/908781?source=tweet\" data-url=\"https://seekingalpha.com/news/908781\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908741\" data-ts=\"1364248597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALL\" target=\"_blank\">CALL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: CALL +6%. TX +5%. KWK +4%. CAR +4%. SONC +5%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/CALL\" title=\"magicJack VocalTec Communications Ltd.\">CALL</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/TX\" title=\"Ternium S.A.\">TX</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/KWK\" title=\"Quicksilver Resources Inc.\">KWK</a> <font color=\"green\">+4%</font>. <a href=\"https://seekingalpha.com/symbol/CAR\" title=\"Avis Budget Group, Inc.\">CAR</a> <font color=\"green\">+4%</font>. <a href=\"https://seekingalpha.com/symbol/SONC\" title=\"Sonic Corp.\">SONC</a> <font color=\"green\">+5%</font>. <br><b>After-hours top losers:</b> <a href=\"https://seekingalpha.com/symbol/HXM\" title=\"Desarrolladora Homex, S.A.B. de C.V. (Homex)\">HXM</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/GMAN\" title=\"Gordmans Stores\">GMAN</a> <font color=\"red\">-5%</font>. <a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a> <font color=\"red\">-5%</font>. <a href=\"https://seekingalpha.com/symbol/MGLN\" title=\"Magellan Health Services, Inc.\">MGLN</a> <font color=\"red\">-2%</font>.<div class=\"tiny-share-widget\" data-id=\"908741\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: CALL +6%. TX +5%. KWK +4%. CAR +4%. SONC +5%....\" data-tweet=\"$CALL $CALL $TX - After-hours top gainers, as of 5:15 p.m.: CALL +6%. TX +5%. KWK +4%. CAR +4%. SONC +5%. After-hours top losers: HXM -9%. GMAN -5%. CLMT -5%. MGLN -2%. https://seekingalpha.com/news/908741?source=tweet\" data-url=\"https://seekingalpha.com/news/908741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908711\" data-ts=\"1364247935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Sonic (NASDAQ:SONC): FQ2 EPS comes in line with estimates, but net earnings soar as...</a></h4><p>More on Sonic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SONC\" title=\"Sonic Corp.\">SONC</a>): FQ2 EPS comes in line with estimates, but net earnings soar as lower costs more than offset a 4% decline in total revenue versus the year-earlier period. Systemwide same-store sales were flat, while same-store sales at company-owned drive-ins improved by 1.9%. The company benefited from lower expenses during the quarter, including a 4% decline in payroll and benefits costs, a 4.6% drop in food and packaging expenses and a 3% decrease in SG&amp;A costs. Shares <font color=\"green\">+4%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"908711\" data-linked=\"More on Sonic (NASDAQ:SONC): FQ2 EPS comes in line with estimates, but net earnings soar as...\" data-tweet=\"$SONC - More on Sonic (NASDAQ:SONC): FQ2 EPS comes in line with estimates, but net earnings soar as lower costs more than offset a 4% decline in total revenue versus the year-earlier period. Systemwide same-store sales were flat, while same-store sales ... https://seekingalpha.com/news/908711?source=tweet\" data-url=\"https://seekingalpha.com/news/908711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908591\" data-ts=\"1364244036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908591\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Pharmaceuticals (TTNP +7.8%) extends gains Monday after rising more than 30% Friday on...</a></h4><p>Titan Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/TTNP\" title=\"Titan Pharmaceuticals, Inc.\">TTNP</a> <font color=\"green\">+7.8%</font>) extends gains Monday after rising more than 30% Friday on news the FDA has <a href=\"https://seekingalpha.com/currents/post/905221\" target=\"_blank\">recommended approval</a> of the company's opioid addiction drug Probuphine. Investors however, are no doubt still stinging from the ~40% dive the stock took last Tuesday.<span class=\"Apple-converted-space\"> </span></p><div class=\"tiny-share-widget\" data-id=\"908591\" data-linked=\"Titan Pharmaceuticals (TTNP +7.8%) extends gains Monday after rising more than 30% Friday on...\" data-tweet=\"$TTNP - Titan Pharmaceuticals (TTNP +7.8%) extends gains Monday after rising more than 30% Friday on news the FDA has recommended approval of the company&#39;s opioid addiction drug Probuphine. Investors however, are no doubt still stinging from the ~40% di... https://seekingalpha.com/news/908591?source=tweet\" data-url=\"https://seekingalpha.com/news/908591\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908581\" data-ts=\"1364243968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POL\" target=\"_blank\">POL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PolyOne (POL -1.8%) finishes the day in the red after saying earlier it&#39;s agreed to sell its...</a></h4><p>PolyOne (<a href=\"https://seekingalpha.com/symbol/POL\" title=\"PolyOne Corporation\">POL</a> <font color=\"red\">-1.8%</font>) finishes the day in the red after saying earlier it's agreed to sell its vinyl dispersion, blending and suspension resin assets to Mexichem, S.A.B. de C.V. for $250M in cash. PolyOne's resin assets are part of its Performance Products and Solutions segment and generated revenues of $147M in 2012.</p><div class=\"tiny-share-widget\" data-id=\"908581\" data-linked=\"PolyOne (POL -1.8%) finishes the day in the red after saying earlier it&#39;s agreed to sell its...\" data-tweet=\"$POL - PolyOne (POL -1.8%) finishes the day in the red after saying earlier it&#39;s agreed to sell its vinyl dispersion, blending and suspension resin assets to Mexichem, S.A.B. de C.V. for $250M in cash. PolyOne&#39;s resin assets are part of its Performance ... https://seekingalpha.com/news/908581?source=tweet\" data-url=\"https://seekingalpha.com/news/908581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908501\" data-ts=\"1364242894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLMT\" target=\"_blank\">CLMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908501\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Calumet Specialty Products (NASDAQ:CLMT) -4.6% AH after announcing a public offering of 5.25M...</a></h4><p>Calumet Specialty Products (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a>) <font color=\"red\">-4.6%</font> AH after announcing a public offering of 5.25M common units. CLMT says it intends to use net proceeds for general partnership purposes, including working capital, capital expenditures, acquisitions and possibly pay down debt.</p><div class=\"tiny-share-widget\" data-id=\"908501\" data-linked=\"Calumet Specialty Products (NASDAQ:CLMT) -4.6% AH after announcing a public offering of 5.25M...\" data-tweet=\"$CLMT - Calumet Specialty Products (NASDAQ:CLMT) -4.6% AH after announcing a public offering of 5.25M common units. CLMT says it intends to use net proceeds for general partnership purposes, including working capital, capital expenditures, acquisitions ... https://seekingalpha.com/news/908501?source=tweet\" data-url=\"https://seekingalpha.com/news/908501\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908471\" data-ts=\"1364242503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSI\" target=\"_blank\">VSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vitamin Shoppe (VSI -2.4%) slips today, despite its earlier announcement that it&#39;s opened its...</a></h4><p>Vitamin Shoppe (<a href=\"https://seekingalpha.com/symbol/VSI\" title=\"Vitamin Shoppe, Inc.\">VSI</a> <font color=\"red\">-2.4%</font>) slips today, despite its earlier announcement that it's opened its first international franchised Vitamin Shoppe store in Panama City, Panama.</p><div class=\"tiny-share-widget\" data-id=\"908471\" data-linked=\"Vitamin Shoppe (VSI -2.4%) slips today, despite its earlier announcement that it&#39;s opened its...\" data-tweet=\"$VSI - Vitamin Shoppe (VSI -2.4%) slips today, despite its earlier announcement that it&#39;s opened its first international franchised Vitamin Shoppe store in Panama City, Panama. https://seekingalpha.com/news/908471?source=tweet\" data-url=\"https://seekingalpha.com/news/908471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908391\" data-ts=\"1364241893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908391\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic (NASDAQ:SONC): FQ2 EPS of $0.05 in-line. Revenue of $111.4M. Shares +3.9% AH. (PR)</a></h4><b>Sonic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SONC\" title=\"Sonic Corp.\">SONC</a>):</b> FQ2 EPS of $0.05 in-line. Revenue of $111.4M. Shares  <font color=\"green\">+3.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"908391\" data-linked=\"Sonic (NASDAQ:SONC): FQ2 EPS of $0.05 in-line. Revenue of $111.4M. Shares +3.9% AH. (PR)\" data-tweet=\"$SONC - Sonic (NASDAQ:SONC): FQ2 EPS of $0.05 in-line. Revenue of $111.4M. Shares +3.9% AH. (PR) https://seekingalpha.com/news/908391?source=tweet\" data-url=\"https://seekingalpha.com/news/908391\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908331\" data-ts=\"1364241218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPCI\" target=\"_blank\">IPCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908331\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intellipharmaceutics (IPCI -3%) slides after announcing earlier that it&#39;s closed its registered...</a></h4><p>Intellipharmaceutics (<a href=\"https://seekingalpha.com/symbol/IPCI\" title=\"IntelliPharmaCeutics International Inc\">IPCI</a> <font color=\"red\">-3%</font>) slides after announcing earlier that it's closed its registered direct unit offering, raising around $3.1M at a price of S$1.72 per unit. The company sold units consisting of 1.815M common shares and warrants to purchase an additional 453,750 common shares.</p><div class=\"tiny-share-widget\" data-id=\"908331\" data-linked=\"Intellipharmaceutics (IPCI -3%) slides after announcing earlier that it&#39;s closed its registered...\" data-tweet=\"$IPCI - Intellipharmaceutics (IPCI -3%) slides after announcing earlier that it&#39;s closed its registered direct unit offering, raising around $3.1M at a price of S$1.72 per unit. The company sold units consisting of 1.815M common shares and warrants to p... https://seekingalpha.com/news/908331?source=tweet\" data-url=\"https://seekingalpha.com/news/908331\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908321\" data-ts=\"1364240597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUR\" target=\"_blank\">CUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neuralstem (CUR -2.7%) slips after earlier saying it&#39;s secured $8M in debt financing from...</a></h4><p>Neuralstem (<a href=\"https://seekingalpha.com/symbol/CUR\" title=\"Neuralstem, Inc.\">CUR</a> <font color=\"red\">-2.7%</font>) slips after earlier saying it's secured $8M in <a href=\"https://seekingalpha.com/market_currents/post/https://seekingalpha.com/news-article/6044991-neuralstem-secures-8-million-in-debt-financing-from-hercules\" target=\"_blank\">debt financing</a> from Hercules Technology to fund the company's capital budget through late 2014. The company has multiple cell therapy clinical trials planned this year, including upcoming Phase 2 ALS trials in the U.S.</p><div class=\"tiny-share-widget\" data-id=\"908321\" data-linked=\"Neuralstem (CUR -2.7%) slips after earlier saying it&#39;s secured $8M in debt financing from...\" data-tweet=\"$CUR $SNCA - Neuralstem (CUR -2.7%) slips after earlier saying it&#39;s secured $8M in debt financing from Hercules Technology to fund the company&#39;s capital budget through late 2014. The company has multiple cell therapy clinical trials planned this year, i... https://seekingalpha.com/news/908321?source=tweet\" data-url=\"https://seekingalpha.com/news/908321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908311\" data-ts=\"1364240105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908311\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Tesla Motors (TSLA +3.8%) move higher after CEO/founder Elon Musk tweets that he will...</a></h4><p>Shares of Tesla Motors (<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a> <font color=\"green\">+3.8%</font>) move higher after CEO/founder Elon Musk <a href=\"https://twitter.com/elonmusk/status/316260319360061440\" target=\"_blank\">tweets</a> that he will be making an announcement on Thursday about putting his money where his mouth is. One idea being <a href=\"https://twitter.com/thenotablecalls/status/316264321694978049\" target=\"_blank\">floating around</a> is that Musk will fire up a secondary offering of which he takes a big chunk and uses the proceeds to pay back the automaker's outstanding DOE loan.</p><div class=\"tiny-share-widget\" data-id=\"908311\" data-linked=\"Shares of Tesla Motors (TSLA +3.8%) move higher after CEO/founder Elon Musk tweets that he will...\" data-tweet=\"$TSLA - Shares of Tesla Motors (TSLA +3.8%) move higher after CEO/founder Elon Musk tweets that he will be making an announcement on Thursday about putting his money where his mouth is. One idea being floating around is that Musk will fire up a secondar... https://seekingalpha.com/news/908311?source=tweet\" data-url=\"https://seekingalpha.com/news/908311\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908291\" data-ts=\"1364239680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUXL\" target=\"_blank\">AUXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auxilium Pharmaceuticals (AUXL +3%) trades higher today after reporting positive top-line data...</a></h4><p>Auxilium Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/AUXL\" title=\"Auxilium Pharmaceuticals, Inc.\">AUXL</a> <font color=\"green\">+3%</font>) trades higher today after reporting positive top-line data from Phase II studies of its investigational treatment, Xiaflex, for adhesive capsulitis or Frozen Shoulder syndrome. The company said that the trial achieved statistically significant improvement in active forward flexion in the affected shoulder of patients compared to those who were only instructed to perform home shoulder exercises, its primary endpoint. It expects to commence the next phase trials for in H213.</p><div class=\"tiny-share-widget\" data-id=\"908291\" data-linked=\"Auxilium Pharmaceuticals (AUXL +3%) trades higher today after reporting positive top-line data...\" data-tweet=\"$AUXL - Auxilium Pharmaceuticals (AUXL +3%) trades higher today after reporting positive top-line data from Phase II studies of its investigational treatment, Xiaflex, for adhesive capsulitis or Frozen Shoulder syndrome. The company said that the trial ... https://seekingalpha.com/news/908291?source=tweet\" data-url=\"https://seekingalpha.com/news/908291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908221\" data-ts=\"1364238029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HZNP\" target=\"_blank\">HZNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horizon Pharmaceutical (HZNP +11%) trades up today on the back of a positive article in Seeking...</a></h4><p>Horizon Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/HZNP\" title=\"Horizon Pharma plc\">HZNP</a> <font color=\"green\">+11%</font>) trades up today on the back of a <a href=\"https://seekingalpha.com/article/1297121-has-horizon-pharma-s-share-price-bottomed-out?source=yahoo\" target=\"_blank\">positive article</a> in Seeking Alpha, saying that the company has transitioned from a drug developer to an integrated commercial pharmaceutical company as the result of the FDA's approval of Duexis and Rayos/Lodotra. The stock has been beaten down since its high last year of $8.72. and now, a under $3, is a bargain.</p><div class=\"tiny-share-widget\" data-id=\"908221\" data-linked=\"Horizon Pharmaceutical (HZNP +11%) trades up today on the back of a positive article in Seeking...\" data-tweet=\"$HZNP - Horizon Pharmaceutical (HZNP +11%) trades up today on the back of a positive article in Seeking Alpha, saying that the company has transitioned from a drug developer to an integrated commercial pharmaceutical company as the result of the FDA&#39;s a... https://seekingalpha.com/news/908221?source=tweet\" data-url=\"https://seekingalpha.com/news/908221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908211\" data-ts=\"1364237954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTI\" target=\"_blank\">TTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908211\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetra Tech (TTI +5.3%) is upgraded to Sector Outperform by Howard Weil, which sees higher...</a></h4><p>Tetra Tech (<a href=\"https://seekingalpha.com/symbol/TTI\" title=\"Tetra Technologies Inc.\">TTI</a> <font color=\"green\">+5.3%</font>) is <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/Howard+Weil+Upgrades+TETRA+Technologies+Inc.+%28TTI%29+to+Outperform/8208330.html\">upgraded</a> to Sector Outperform by Howard Weil, which sees higher margins ahead. TTI's outlook in fluids calls for a return to near pre-Macondo levels of activity in the Gulf of Mexico, while holdover work from 2012 delays along with high early-year quotations and a streamlined permitting process argue for an improving Y/Y outlook in offshore services.</p><div class=\"tiny-share-widget\" data-id=\"908211\" data-linked=\"Tetra Tech (TTI +5.3%) is upgraded to Sector Outperform by Howard Weil, which sees higher...\" data-tweet=\"$TTI - Tetra Tech (TTI +5.3%) is upgraded to Sector Outperform by Howard Weil, which sees higher margins ahead. TTI&#39;s outlook in fluids calls for a return to near pre-Macondo levels of activity in the Gulf of Mexico, while holdover work from 2012 delays... https://seekingalpha.com/news/908211?source=tweet\" data-url=\"https://seekingalpha.com/news/908211\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908191\" data-ts=\"1364237275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPRX\" target=\"_blank\">RPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Repros Therapeutics (RPRX +6.9%) ticks higher today after the American Urological Association...</a></h4><p>Repros Therapeutics (<a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> <font color=\"green\">+6.9%</font>) ticks higher today after the American Urological Association accepted key data on it's Androxal for presentation at the annual meeting in San Diego in May. The data that will be presented are from studies of two doses of Androxal with open label on demand Testim gel in 120 patients with secondary hypogonadism, and aims to prove that Androxal may provide effective therapy in men with the condition, particularly in those wishing to preserve fertility.</p><div class=\"tiny-share-widget\" data-id=\"908191\" data-linked=\"Repros Therapeutics (RPRX +6.9%) ticks higher today after the American Urological Association...\" data-tweet=\"$RPRX - Repros Therapeutics (RPRX +6.9%) ticks higher today after the American Urological Association accepted key data on it&#39;s Androxal for presentation at the annual meeting in San Diego in May. The data that will be presented are from studies of two ... https://seekingalpha.com/news/908191?source=tweet\" data-url=\"https://seekingalpha.com/news/908191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908181\" data-ts=\"1364237118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China says growth in its crude steel production this year likely will be a more moderate 4%...</a></h4><p>China says growth in its crude steel production this year likely will be a <a href=\"http://online.wsj.com/article/SB10001424127887324789504578382052619598938.html\" target=\"_blank\">more moderate 4%</a> compared with the breakneck pace of much of the past decade. The slow recovery of developed economies means global demand will grow only gradually, the country's top planning agency says. The world's top three iron ore miners, which seem to expect better, are <a href=\"http://247wallst.com/2013/03/25/chinese-steel-production-to-slow-big-miners-could-suffer/\" target=\"_blank\">slipping</a>: <a href=\"https://seekingalpha.com/symbol/VALE\" title=\"Vale S.A.\">VALE</a> <font color=\"red\">-1.3%</font>, <a href=\"https://seekingalpha.com/symbol/RIO\" title=\"Rio Tinto plc\">RIO</a> <font color=\"red\">-1.5%</font>, <a href=\"https://seekingalpha.com/symbol/BHP\" title=\"BHP Billiton Limited\">BHP</a> <font color=\"red\">-1%</font>.</p><div class=\"tiny-share-widget\" data-id=\"908181\" data-linked=\"China says growth in its crude steel production this year likely will be a more moderate 4%...\" data-tweet=\"$VALE $VALE $RIO - China says growth in its crude steel production this year likely will be a more moderate 4% compared with the breakneck pace of much of the past decade. The slow recovery of developed economies means global demand will grow only gradu... https://seekingalpha.com/news/908181?source=tweet\" data-url=\"https://seekingalpha.com/news/908181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908131\" data-ts=\"1364235823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCYC\" target=\"_blank\">PCYC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pharmacyclics (PCYC +2.3%) gains today on the back of positive comments out of Credit Suisse,...</a></h4><p>Pharmacyclics (<a href=\"https://seekingalpha.com/symbol/PCYC\" title=\"Pharmacyclics, Inc.\">PCYC</a> <font color=\"green\">+2.3%</font>) gains today on the back of <a href=\"http://investorshub.advfn.com/boards/read_msg.aspx?message_id=86062867\" target=\"_blank\">positive comments</a> out of Credit Suisse, saying they're excited about the multi-billion dollar potential of its lymphoma/leukemia drug ibrutinib, and see the recent weakness in the shares as a possible entry point. The firm has a target price of $90, which looks attainable with a number of positive catalysts on the horizon.</p><div class=\"tiny-share-widget\" data-id=\"908131\" data-linked=\"Pharmacyclics (PCYC +2.3%) gains today on the back of positive comments out of Credit Suisse,...\" data-tweet=\"$PCYC - Pharmacyclics (PCYC +2.3%) gains today on the back of positive comments out of Credit Suisse, saying they&#39;re excited about the multi-billion dollar potential of its lymphoma/leukemia drug ibrutinib, and see the recent weakness in the shares as a... https://seekingalpha.com/news/908131?source=tweet\" data-url=\"https://seekingalpha.com/news/908131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908121\" data-ts=\"1364235755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USG\" target=\"_blank\">USG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908121\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The steep afternoon drop in shares of USG (USG -5.5%) and Eagle Materials (EGLE -2.2%) is tied...</a></h4><p>The steep afternoon drop in shares of USG (<a href=\"https://seekingalpha.com/symbol/USG\" title=\"USG Corporation\">USG</a> <font color=\"red\">-5.5%</font>) and Eagle Materials (<a href=\"https://seekingalpha.com/symbol/EGLE\" title=\"Eagle Bulk Shipping Inc.\">EGLE</a> <font color=\"red\">-2.2%</font>) is tied to a research note by analysts at Cleveland Research, which says its checks showed <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/03/3443992/eagle-materials-shares-underperforming-following-concern\" target=\"_blank\">slippage in wallboard pricing</a>, especially in the eastern U.S. Shares had plunged 9.2% and 4.5%, respectively, at their lowest points about an hour ago.</p><div class=\"tiny-share-widget\" data-id=\"908121\" data-linked=\"The steep afternoon drop in shares of USG (USG -5.5%) and Eagle Materials (EGLE -2.2%) is tied...\" data-tweet=\"$USG $USG $EGLE - The steep afternoon drop in shares of USG (USG -5.5%) and Eagle Materials (EGLE -2.2%) is tied to a research note by analysts at Cleveland Research, which says its checks showed slippage in wallboard pricing, especially in the eastern ... https://seekingalpha.com/news/908121?source=tweet\" data-url=\"https://seekingalpha.com/news/908121\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908051\" data-ts=\"1364233379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908051\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo and Jefferies do their best to defend BlackBerry (BBRY -3.6%) as shares fall due to...</a></h4><a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Blackberry+%28BBRY%29+Z10+Progressing+as+Expected%2C+Says+Wells+Fargo%3B+Goldman+Disagrees/8208329.html\">Wells Fargo</a> and <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/BlackBerry+%28BBRY%29+U.S.+Z10+Launch+Slightly+Above+Modest+Expectations+-+Jefferies/8207875.html\">Jefferies</a> do their best to defend BlackBerry (BBRY <font color=\"red\">-3.6%</font>) as shares fall due to <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/906821\">Goldman's downgrade</a> and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/905611\">reports</a> of a soft AT&amp;T Z10 launch. \"We think demand is slightly better than our very modest expectations,\" writes Jefferies' Peter Misek after conducting checks at 30+ stores. He adds Z10 interest from AT&amp;T's business channels is healthy, and that checks indicate Verizon's business sales are strong. Wells Fargo's Maynard Um says he thinks Z10 sales to BlackBerry's installed base remain solid.<div class=\"tiny-share-widget\" data-id=\"908051\" data-linked=\"Wells Fargo and Jefferies do their best to defend BlackBerry (BBRY -3.6%) as shares fall due to...\" data-tweet=\"$BB - Wells Fargo and Jefferies do their best to defend BlackBerry (BBRY -3.6%) as shares fall due to Goldman&#39;s downgrade and reports of a soft AT&amp;T Z10 launch. &quot;We think demand is slightly better than our very modest expectations,&quot; writes Jefferies&#39; Pe... https://seekingalpha.com/news/908051?source=tweet\" data-url=\"https://seekingalpha.com/news/908051\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"908041\" data-ts=\"1364232897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/908041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mast Therapeutics (MSTX +1.4%) gains today after the European Commission granted orphan-drug...</a></h4><p>Mast Therapeutics (MSTX <font color=\"green\">+1.4%</font>) gains today after the European Commission <a href=\"http://www.prnewswire.com/news-releases/european-commission-designates-mst-188-as-an-orphan-medicinal-product-199838121.html\" target=\"_blank\">granted orphan-drug designation</a> to it's MST-188 drug candidate, a potential treatment for sickle cell disease. The decision gives MSTX 10 years of marketing exclusivity, and follows a similar positive opinion by the Committee for Orphan Medicinal Products. The company says it expects to now pursue strategic alliances \"more aggressively.\"</p><div class=\"tiny-share-widget\" data-id=\"908041\" data-linked=\"Mast Therapeutics (MSTX +1.4%) gains today after the European Commission granted orphan-drug...\" data-tweet=\"$SVRA - Mast Therapeutics (MSTX +1.4%) gains today after the European Commission granted orphan-drug designation to it&#39;s MST-188 drug candidate, a potential treatment for sickle cell disease. The decision gives MSTX 10 years of marketing exclusivity, an... https://seekingalpha.com/news/908041?source=tweet\" data-url=\"https://seekingalpha.com/news/908041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907991\" data-ts=\"1364231548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RBBN\" target=\"_blank\">RBBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle&#39;s newfound love of telecom acquisitions continues to do wonders for Sonus (SONS +7.9%)...</a></h4><p>Oracle's newfound love of telecom acquisitions continues to do wonders for Sonus (SONS <font color=\"green\">+7.9%</font>) and BroadSoft (BSFT <font color=\"green\">+5.4%</font>) shares. 6 weeks after their shares <a href=\"https://seekingalpha.com/currents/post/801331\" target=\"_blank\">jumped</a> thanks to Oracle's deal to acquire <a href=\"https://seekingalpha.com/currents/post/800911\" target=\"_blank\">Acme Packet</a>, they're rallying on news of its acquisition of <a href=\"https://seekingalpha.com/currents/post/907501\" target=\"_blank\">Tekelec</a>. BroadSoft was crushed last month after providing <a href=\"https://seekingalpha.com/currents/post/856431\" target=\"_blank\">light guidance</a> to go with a <a href=\"https://seekingalpha.com/currents/post/856111\" target=\"_blank\">Q4 beat</a>.</p><div class=\"tiny-share-widget\" data-id=\"907991\" data-linked=\"Oracle&#39;s newfound love of telecom acquisitions continues to do wonders for Sonus (SONS +7.9%)...\" data-tweet=\"$RBBN $RBBN $CSCO - Oracle&#39;s newfound love of telecom acquisitions continues to do wonders for Sonus (SONS +7.9%) and BroadSoft (BSFT +5.4%) shares. 6 weeks after their shares jumped thanks to Oracle&#39;s deal to acquire Acme Packet, they&#39;re rallying on ne... https://seekingalpha.com/news/907991?source=tweet\" data-url=\"https://seekingalpha.com/news/907991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907961\" data-ts=\"1364230890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple (NASDAQ:AAPL) &quot;will introduce the first 64-bit ARM-based chip this year,&quot; writes...</a></h4><p>Apple (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a>) \"will introduce the first 64-bit ARM-based chip this year,\" <a target=\"_blank\" href=\"http://blogs.barrons.com/techtraderdaily/2013/03/25/amcc-cavm-armh-intc-aapl-evercore-ponders-server-prospects/\">writes</a> Evercore's Patrick Wang. Wang doesn't state which Apple products the chip will go into, but does note the adoption of 64-bit parts will lift ARM's (<a href=\"https://seekingalpha.com/symbol/ARMH\" title=\"ARM Holdings, plc\">ARMH</a> <font color=\"green\">+3.4%</font>) royalty rates. He also sees a 2H ramp in chips using ARM's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=armh%20big.little\">big.LITTLE architecture</a> boosting rates, and talks up the potential of ARM server CPUs from Applied Micro (<a href=\"https://seekingalpha.com/symbol/AMCC\" title=\"Applied Micro Circuits Corporation\">AMCC</a> <font color=\"red\">-1.5%</font>) and Cavium (CAVM <font color=\"red\">-0.5%</font>) - Wang sees AMCC's <a target=\"_blank\" href=\"http://www.anandtech.com/show/5027/appliedmicro-announces-xgene-arm-based-socs-for-cloud-computing\">X-Gene CPU</a> cementing its early lead in the market. ARM announced its 64-bit <a target=\"_blank\" href=\"http://www.pcworld.com/article/2013298/arm-introduces-64bit-processors-for-phones-tablets-and-servers.html\">Cortex-A50 cores</a> in October. (previous: <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/619731\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/816811\">II</a>)</p><div class=\"tiny-share-widget\" data-id=\"907961\" data-linked=\"Apple (NASDAQ:AAPL) &quot;will introduce the first 64-bit ARM-based chip this year,&quot; writes...\" data-tweet=\"$AAPL $AAPL $ARMH - Apple (NASDAQ:AAPL) &quot;will introduce the first 64-bit ARM-based chip this year,&quot; writes Evercore&#39;s Patrick Wang. Wang doesn&#39;t state which Apple products the chip will go into, but does note the adoption of 64-bit parts will lift ARM&#39;s... https://seekingalpha.com/news/907961?source=tweet\" data-url=\"https://seekingalpha.com/news/907961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907951\" data-ts=\"1364230763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEO\" target=\"_blank\">CEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cnooc (CEO +3.2%) shares rise as BAML lifts shares to Buy from Neutral, backing management&#39;s...</a></h4><p>Cnooc (<a href=\"https://seekingalpha.com/symbol/CEO\" title=\"CNOOC Limited\">CEO</a> <font color=\"green\">+3.2%</font>) shares rise as BAML <a target=\"_blank\" href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/03/3443628/update-bank-of-america-upgrades-cnooc-limited-to-buy-rai\">lifts</a> shares to Buy from Neutral, backing management's positive outlook on volume growth in 2014-15E supported by a solid reserve replacement ratio  (excluding Nexen, 188% in 2012 vs. 158% in 2011), and a very strong  project pipeline of 30-50 new projects in 2013-15. Jefferies <a href=\"http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+CNOOC+Ltd.+%28CEO%29+to+Hold/8208742.html\" target=\"_blank\">also upgrades</a> Cnooc, to Hold from Underperform.</p><div class=\"tiny-share-widget\" data-id=\"907951\" data-linked=\"Cnooc (CEO +3.2%) shares rise as BAML lifts shares to Buy from Neutral, backing management&#39;s...\" data-tweet=\"$CEO - Cnooc (CEO +3.2%) shares rise as BAML lifts shares to Buy from Neutral, backing management&#39;s positive outlook on volume growth in 2014-15E supported by a solid reserve replacement ratio (excluding Nexen, 188% in 2012 vs. 158% in 2011), and a very... https://seekingalpha.com/news/907951?source=tweet\" data-url=\"https://seekingalpha.com/news/907951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907931\" data-ts=\"1364230130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVIV\" target=\"_blank\">AVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aviv REIT (NYSE:AVIV) is up 15% from its Thursday IPO, with SA Pro author Dane Bowler suggesting...</a></h4><p>Aviv REIT (NYSE:<a href=\"https://seekingalpha.com/symbol/AVIV\" title=\"Aviv REIT\">AVIV</a>) is up 15% from its Thursday IPO, with SA Pro author Dane Bowler suggesting the stock as a play for healthcare REIT fans<a href=\"https://seekingalpha.com/article/1294561-aviv-reit-a-new-contender-in-the-promising-healthcare-sector\" target=\"_blank\"> looking for better values</a> after the big move higher in <a href=\"https://seekingalpha.com/symbol/OHI\" title=\"Omega Healthcare Investors, Inc\">OHI</a>.  Don't be put off by a current price-FFO ratio of 14.39, he says, as this excludes $251M dollars from the IPO which have yet to be invested as well as much benefit from the company's 2012 acquisitions.</p><div class=\"tiny-share-widget\" data-id=\"907931\" data-linked=\"Aviv REIT (NYSE:AVIV) is up 15% from its Thursday IPO, with SA Pro author Dane Bowler suggesting...\" data-tweet=\"$AVIV $AVIV $OHI - Aviv REIT (NYSE:AVIV) is up 15% from its Thursday IPO, with SA Pro author Dane Bowler suggesting the stock as a play for healthcare REIT fans looking for better values after the big move higher in OHI.  Don&#39;t be put off by a current p... https://seekingalpha.com/news/907931?source=tweet\" data-url=\"https://seekingalpha.com/news/907931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907921\" data-ts=\"1364230032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STXS\" target=\"_blank\">STXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907921\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: STXS +56%. VBFC +14%. LEDS +13%. ERII +11%. VECO +11%. HZNP +10%. APOL...</a></h4><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/STXS' title='Stereotaxis, Inc.'>STXS</a> <font color=\"green\">+56%</font>. <a href='https://seekingalpha.com/symbol/VBFC' title='Village Bank and Trust Financial Corp.'>VBFC</a> <font color=\"green\">+14%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color=\"green\">+13%</font>. <a href='https://seekingalpha.com/symbol/ERII' title='Energy Recovery, Inc.'>ERII</a> <font color=\"green\">+11%</font>. <a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a> <font color=\"green\">+11%</font>. <a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/APOL' title='Apollo Education Group, Inc.'>APOL</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/SRT' title='StarTek, Inc.'>SRT</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/EQU' title='Equal Energy Ltd.'>EQU</a> <font color=\"green\">+9%</font>.<br /> <b>Midday top 10 losers:</b> <a href='https://seekingalpha.com/symbol/PGTI' title='PGT Innovations, Inc.'>PGTI</a> <font color=\"red\">-16%</font>. <a href='https://seekingalpha.com/symbol/IDIX' title='Idenix Pharmaceuticals, Inc.'>IDIX</a> <font color=\"red\">-15%</font>. <a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/TSL' title='Trina Solar Limited'>TSL</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color=\"red\">-11%</font>. FREE <font color=\"red\">-10%</font>. <a href='https://seekingalpha.com/symbol/JE' title='Just Energy Group, Inc.'>JE</a> <font color=\"red\">-10%</font>. <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a> <font color=\"red\">-10%</font>. <a href='https://seekingalpha.com/symbol/BWEN' title='Broadwind Energy, Inc.'>BWEN</a> <font color=\"red\">-10%</font>.<div class=\"tiny-share-widget\" data-id=\"907921\" data-linked=\"Midday top 10 gainers: STXS +56%. VBFC +14%. LEDS +13%. ERII +11%. VECO +11%. HZNP +10%. APOL...\" data-tweet=\"$STXS $STXS $VBFC - Midday top 10 gainers: STXS +56%. VBFC +14%. LEDS +13%. ERII +11%. VECO +11%. HZNP +10%. APOL +10%. SRT +10%. GSV +10%. EQU +9%. Midday top 10 losers: PGTI -16%. IDIX -15%. JASO -13%. TSL -13%. TOPS -13%. VHC -11%. FREE -10%. JE -10%... https://seekingalpha.com/news/907921?source=tweet\" data-url=\"https://seekingalpha.com/news/907921\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907911\" data-ts=\"1364229655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDC\" target=\"_blank\">DDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harry Winston Diamond (HWD -1.7%) is downgraded to Market Perform by BMO due to valuation,...</a></h4><p>Harry Winston Diamond (HWD <font color=\"red\">-1.7%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/03/3443136/update-bmo-capital-markets-downgrades-harry-winston-diam\" target=\"_blank\">downgraded</a> to Market Perform by BMO due to valuation, saying the stock is trading at attractive forward EV/EBITDA multiples but also reasonably priced relative to the execution risk related to the Ekati transaction. If release of the Ekati mine plan confirms the firm's estimates and forward valuation multiples, further upside potential should be unlocked.</p><div class=\"tiny-share-widget\" data-id=\"907911\" data-linked=\"Harry Winston Diamond (HWD -1.7%) is downgraded to Market Perform by BMO due to valuation,...\" data-tweet=\"$DDC - Harry Winston Diamond (HWD -1.7%) is downgraded to Market Perform by BMO due to valuation, saying the stock is trading at attractive forward EV/EBITDA multiples but also reasonably priced relative to the execution risk related to the Ekati transa... https://seekingalpha.com/news/907911?source=tweet\" data-url=\"https://seekingalpha.com/news/907911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907901\" data-ts=\"1364229418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSL\" target=\"_blank\">TSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907901\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solar stocks slump after JA Solar misses Q4 EPS estimates (while beating revenue estimates)...</a></h4>Solar stocks slump after JA Solar <a href=\"https://seekingalpha.com/currents/post/906561\" target=\"_blank\">misses</a> Q4 EPS estimates (while beating revenue estimates) thanks to a -4.6% gross margin, and forecasts a <a href=\"https://seekingalpha.com/currents/post/906991\" target=\"_blank\">major Q/Q shipment drop</a>. <a href='https://seekingalpha.com/symbol/TSL' title='Trina Solar Limited'>TSL</a> <font color=\"red\">-13.3%</font>. <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a> <font color=\"red\">-11.1%</font>. <a href='https://seekingalpha.com/symbol/SOL' title='ReneSola Ltd.'>SOL</a> <font color=\"red\">-5.7%</font>. <a href='https://seekingalpha.com/symbol/LDK' title='LDK Solar Co., Ltd.'>LDK</a> <font color=\"red\">-4.1%</font>. <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color=\"red\">-4.4%</font>. <a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color=\"red\">-3.1%</font>. <a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color=\"red\">-2.6%</font>. <a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color=\"red\">-2.8%</font>.<div class=\"tiny-share-widget\" data-id=\"907901\" data-linked=\"Solar stocks slump after JA Solar misses Q4 EPS estimates (while beating revenue estimates)...\" data-tweet=\"$TSL $TSL $YGE - Solar stocks slump after JA Solar misses Q4 EPS estimates (while beating revenue estimates) thanks to a -4.6% gross margin, and forecasts a major Q/Q shipment drop. TSL -13.3%. YGE -11.1%. SOL -5.7%. LDK -4.1%. CSIQ -4.4%. JKS -3.1%. FS... https://seekingalpha.com/news/907901?source=tweet\" data-url=\"https://seekingalpha.com/news/907901\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907861\" data-ts=\"1364228716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James downgrades Red Hat (RHT -5.2%) to Market Perform two days before its FQ4 report...</a></h4><a href=\"http://finance.yahoo.com/news/red-hat-shares-fall-raymond-153130054.html\" target=\"_blank\">Raymond James downgrades</a> Red Hat (<a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a> <font color=\"red\">-5.2%</font>) to Market Perform two days before its FQ4 report arrives. Analyst Michael Turtis expects FQ4 results to meet expectations, but thinks the enterprise software vendor's FY14 guidance could disappoint. Red Hat is <font color=\"red\">down 16%</font> from its early Feb. high, and close to its 52-week low. <a href=\"https://seekingalpha.com/currents/post/884441\" target=\"_blank\">Citi downgraded shares</a> on March 12.<div class=\"tiny-share-widget\" data-id=\"907861\" data-linked=\"Raymond James downgrades Red Hat (RHT -5.2%) to Market Perform two days before its FQ4 report...\" data-tweet=\"$RHT - Raymond James downgrades Red Hat (RHT -5.2%) to Market Perform two days before its FQ4 report arrives. Analyst Michael Turtis expects FQ4 results to meet expectations, but thinks the enterprise software vendor&#39;s FY14 guidance could disappoint. Re... https://seekingalpha.com/news/907861?source=tweet\" data-url=\"https://seekingalpha.com/news/907861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907831\" data-ts=\"1364228272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907831\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia Pharmaceuticals (ACAD +10.1%) gets a big bump on a notable mention from Jim Cramer last...</a></h4><p>Acadia Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ACAD\" title=\"ACADIA Pharmaceuticals Inc.\">ACAD</a> <font color=\"green\">+10.1%</font>) gets a big bump on a <a target=\"_blank\" href=\"https://seekingalpha.com/article/1297151-cramer-s-lightning-round-i-didn-t-get-to-the-promised-land-with-energy-transfer-partners-3-22-13\">notable mention</a> from Jim Cramer last Friday CNBC's on <i>Mad Money</i>. \"This is the real deal,\" He says. \"There was some profit taking this week, but you should hold onto it. <a href=\"https://seekingalpha.com/symbol/ACAD\" title=\"ACADIA Pharmaceuticals Inc.\">ACAD</a> is a fantastic spec.\" Additionally, Seeking Alpha contributor Brian Nichols added his two cents as well, calling the stock the <a target=\"_blank\" href=\"https://seekingalpha.com/article/1298081-last-week-s-biotech-movers-are-any-a-buy\">safest bet</a> in the biotech space right now after Pimavanserin's encouraging <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/903171\">Phase 3 trial results</a>.</p><div class=\"tiny-share-widget\" data-id=\"907831\" data-linked=\"Acadia Pharmaceuticals (ACAD +10.1%) gets a big bump on a notable mention from Jim Cramer last...\" data-tweet=\"$ACAD - Acadia Pharmaceuticals (ACAD +10.1%) gets a big bump on a notable mention from Jim Cramer last Friday CNBC&#39;s on Mad Money. &quot;This is the real deal,&quot; He says. &quot;There was some profit taking this week, but you should hold onto it. ACAD is a fantasti... https://seekingalpha.com/news/907831?source=tweet\" data-url=\"https://seekingalpha.com/news/907831\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907791\" data-ts=\"1364227104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHS\" target=\"_blank\">VHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907791\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Vanguard Health Systems (VHS -8.44%) take a hit today after the company announced that...</a></h4><p>Shares of  Vanguard Health Systems (<a href=\"https://seekingalpha.com/symbol/VHS\" title=\"Vanguard Health Systems\">VHS</a> <font color=\"red\">-8.44%</font>) take a hit today after the company announced that it had surprisingly lost a contract covering Medicaid patients in Arizona over the weekend. Magellan Health Services (<a href=\"https://seekingalpha.com/symbol/MGLN\" title=\"Magellan Health Services, Inc.\">MGLN</a> <font color=\"red\">-4.2%</font>) also takes some of the heat, as it operates a joint venture for behavioral health with <a href=\"https://seekingalpha.com/symbol/VHS\" title=\"Vanguard Health Systems\">VHS</a> in the state.</p><div class=\"tiny-share-widget\" data-id=\"907791\" data-linked=\"Shares of Vanguard Health Systems (VHS -8.44%) take a hit today after the company announced that...\" data-tweet=\"$VHS $VHS $MGLN - Shares of Vanguard Health Systems (VHS -8.44%) take a hit today after the company announced that it had surprisingly lost a contract covering Medicaid patients in Arizona over the weekend. Magellan Health Services (MGLN -4.2%) also tak... https://seekingalpha.com/news/907791?source=tweet\" data-url=\"https://seekingalpha.com/news/907791\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907771\" data-ts=\"1364226744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDIX\" target=\"_blank\">IDIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Idenix Pharmaceuticals (IDIX -12.6%) slips back near its lows for the day, after the USPTO...</a></h4><p>Idenix Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/IDIX\" title=\"Idenix Pharmaceuticals, Inc.\">IDIX</a> <font color=\"red\">-12.6%</font>) slips back near its lows for the day, after the USPTO <a href=\"https://seekingalpha.com/market_currents/post/906011\" target=\"_blank\">decided against it</a> late Friday in the first phase of a two-stage interference process regarding the biopharmaceutical company's patent applications for certain compounds for treating hepatitis C.</p><div class=\"tiny-share-widget\" data-id=\"907771\" data-linked=\"Idenix Pharmaceuticals (IDIX -12.6%) slips back near its lows for the day, after the USPTO...\" data-tweet=\"$IDIX - Idenix Pharmaceuticals (IDIX -12.6%) slips back near its lows for the day, after the USPTO decided against it late Friday in the first phase of a two-stage interference process regarding the biopharmaceutical company&#39;s patent applications for ce... https://seekingalpha.com/news/907771?source=tweet\" data-url=\"https://seekingalpha.com/news/907771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907681\" data-ts=\"1364224798\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STXS\" target=\"_blank\">STXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stereotaxis (STXS +70%) soars after receiving regulatory approval of its Niobe remote magnetic...</a></h4><p>Stereotaxis (<a href=\"https://seekingalpha.com/symbol/STXS\" title=\"Stereotaxis, Inc.\">STXS</a> <font color=\"green\">+70%</font>) soars after receiving regulatory approval of its Niobe remote magnetic technology for cardiac ablations in Japan earlier this morning. The approval, which is a critical milestone in securing full market entry into the country, will allow the company to begin establishing a local business infrastructure with in-country distributors, while simultaneously working on obtaining reimbursement approval for full commercial entry.</p><div class=\"tiny-share-widget\" data-id=\"907681\" data-linked=\"Stereotaxis (STXS +70%) soars after receiving regulatory approval of its Niobe remote magnetic...\" data-tweet=\"$STXS - Stereotaxis (STXS +70%) soars after receiving regulatory approval of its Niobe remote magnetic technology for cardiac ablations in Japan earlier this morning. The approval, which is a critical milestone in securing full market entry into the cou... https://seekingalpha.com/news/907681?source=tweet\" data-url=\"https://seekingalpha.com/news/907681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907661\" data-ts=\"1364224202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNO\" target=\"_blank\">RNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907661\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rhino Resource Partners (RNO -2.5%) reports a fatal accident at Castle Valley Partners&#39; Mine #4...</a></h4><p>Rhino Resource Partners (<a href=\"https://seekingalpha.com/symbol/RNO\" title=\"Rhino Resource Partners LP\">RNO</a> <font color=\"red\">-2.5%</font>) reports a fatal accident at Castle Valley Partners' Mine #4 in Utah, which has been temporarily idled while federal and state investigations take place.</p><div class=\"tiny-share-widget\" data-id=\"907661\" data-linked=\"Rhino Resource Partners (RNO -2.5%) reports a fatal accident at Castle Valley Partners&#39; Mine #4...\" data-tweet=\"$RNO - Rhino Resource Partners (RNO -2.5%) reports a fatal accident at Castle Valley Partners&#39; Mine #4 in Utah, which has been temporarily idled while federal and state investigations take place. https://seekingalpha.com/news/907661?source=tweet\" data-url=\"https://seekingalpha.com/news/907661\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907651\" data-ts=\"1364224083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBIO\" target=\"_blank\">FBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907651\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coronado Biosciences (CNDO +4.1%) moves up today after Canaccord initated coverage with a Buy...</a></h4><p>Coronado Biosciences (CNDO <font color=\"green\">+4.1%</font>) moves up today after Canaccord <a href=\"http://www.streetinsider.com/New+Coverage/Canaccord+Genuity+Starts+Coronado+Biosciences+%28CNDO%29+at+Buy/8207973.html\" target=\"_blank\">initated coverage</a> with a Buy rating and an $18 price target. Canaccord says it's ecouraged by Phase 2 trials for Trichuris suis ova, a biologic composed of pig whipworm eggs being tested for the treatment of Crohn's disease. The firm notes that the drug has a novel mechanism, and physician feedback indicates a high likelihood of success for the upcoming data, which could be an important catalyst for the stock in H2.</p><div class=\"tiny-share-widget\" data-id=\"907651\" data-linked=\"Coronado Biosciences (CNDO +4.1%) moves up today after Canaccord initated coverage with a Buy...\" data-tweet=\"$FBIO - Coronado Biosciences (CNDO +4.1%) moves up today after Canaccord initated coverage with a Buy rating and an $18 price target. Canaccord says it&#39;s ecouraged by Phase 2 trials for Trichuris suis ova, a biologic composed of pig whipworm eggs being ... https://seekingalpha.com/news/907651?source=tweet\" data-url=\"https://seekingalpha.com/news/907651\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907621\" data-ts=\"1364224063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNCFF\" target=\"_blank\">UNCFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Italy (EWI -3.7%) and Spain (EWP -3.1%) ETFs lead a now-tumbling Europe (FEZ -1.8%) as -...</a></h4><p>The Italy (<a href=\"https://seekingalpha.com/symbol/EWI\" title=\"iShares MSCI Italy Capped ETF\">EWI</a> <font color=\"red\">-3.7%</font>) and Spain (<a href=\"https://seekingalpha.com/symbol/EWP\" title=\"iShares MSCI Spain Capped ETF\">EWP</a> <font color=\"red\">-3.1%</font>) ETFs lead a now-tumbling Europe (<a href=\"https://seekingalpha.com/symbol/FEZ\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a> <font color=\"red\">-1.8%</font>) as - maybe we're being too simplistic here - Eurogroup President Dijsselbloem has more or less <a href=\"https://seekingalpha.com/currents/post/907541\" target=\"_blank\">told anybody with greater than \u20ac100K</a> in deposits at what could be a troubled bank they need to think about getting their money out. Italy's Unicredit and Intesa Sanpaolo are halted down more <font color=\"red\">than 5%</font>. <a href=\"https://seekingalpha.com/symbol/EUFN\" title=\"iShares MSCI Europe Financials Sector Index ETF\">EUFN</a> <font color=\"red\">-2.4%</font>.</p><div class=\"tiny-share-widget\" data-id=\"907621\" data-linked=\"The Italy (EWI -3.7%) and Spain (EWP -3.1%) ETFs lead a now-tumbling Europe (FEZ -1.8%) as -...\" data-tweet=\"$UNCFF $EWI $EWP - The Italy (EWI -3.7%) and Spain (EWP -3.1%) ETFs lead a now-tumbling Europe (FEZ -1.8%) as - maybe we&#39;re being too simplistic here - Eurogroup President Dijsselbloem has more or less told anybody with greater than \u20ac100K in deposits at... https://seekingalpha.com/news/907621?source=tweet\" data-url=\"https://seekingalpha.com/news/907621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907591\" data-ts=\"1364223140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907591\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array BioPharma (ARRY +11%) gets a big boost from an upgrade to Overweight at Piper Jaffray this...</a></h4><p>Array BioPharma (<a href=\"https://seekingalpha.com/symbol/ARRY\" title=\"Array BioPharma Inc.\">ARRY</a> <font color=\"green\">+11%</font>) gets a big boost from an <a href=\"http://www.streetinsider.com/Upgrades/Piper+Jaffray+Upgrades+Array+BioPharma+%28ARRY%29+to+Overweight/8207853.html\" target=\"_blank\">upgrade to Overweight</a> at Piper Jaffray this morning, pushing the stock near a 5-month high. Piper says the company has a host of potentially <a href=\"http://www.arraybiopharma.com/ProductPipeline/Default.asp\" target=\"_blank\">positive study data</a> due out later this year, and several partnering opportunities in FY13 that could bring in non-dilutive funding. This is encouraging, as the company already finished 2012 with $110M of cash, which the firm estimates would get <a href=\"https://seekingalpha.com/symbol/ARRY\" title=\"Array BioPharma Inc.\">ARRY</a> through mid-2014.</p><div class=\"tiny-share-widget\" data-id=\"907591\" data-linked=\"Array BioPharma (ARRY +11%) gets a big boost from an upgrade to Overweight at Piper Jaffray this...\" data-tweet=\"$ARRY - Array BioPharma (ARRY +11%) gets a big boost from an upgrade to Overweight at Piper Jaffray this morning, pushing the stock near a 5-month high. Piper says the company has a host of potentially positive study data due out later this year, and se... https://seekingalpha.com/news/907591?source=tweet\" data-url=\"https://seekingalpha.com/news/907591\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907581\" data-ts=\"1364223120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX (VHC -10.1%) is tumbling to fresh 52-week lows on strong volume, as the Street continues...</a></h4><p>VirnetX (<a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a> <font color=\"red\">-10.1%</font>) is tumbling to fresh 52-week lows on strong volume, as the Street continues weighing the fallout of an <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/889401\">adverse jury ruling</a> in its patent suit against Cisco. Last week, the judge presiding over the suit <a target=\"_blank\" href=\"http://www.investorvillage.com/smbd.asp?mb=8852&amp;mn=41971&amp;pt=msg&amp;mid=12639229\">issued a final judgment</a> declaring 12 VirnetX patent claims <em>are not invalid</em>, and denying all pending motions.</p><div class=\"tiny-share-widget\" data-id=\"907581\" data-linked=\"VirnetX (VHC -10.1%) is tumbling to fresh 52-week lows on strong volume, as the Street continues...\" data-tweet=\"$VHC - VirnetX (VHC -10.1%) is tumbling to fresh 52-week lows on strong volume, as the Street continues weighing the fallout of an adverse jury ruling in its patent suit against Cisco. Last week, the judge presiding over the suit issued a final judgment... https://seekingalpha.com/news/907581?source=tweet\" data-url=\"https://seekingalpha.com/news/907581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907551\" data-ts=\"1364222782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casino stock show strength again with economic forecasts for Macau looking promising. The...</a></h4><p>Casino stock show strength again with <a href=\"http://www.macaubusiness.com/news/macau-economy-to-grow-by-9-7-percent-in-2013-eiu/22468/\" target=\"_blank\">economic forecasts</a> for Macau looking promising. <i>The Economist</i> sees 9.7% growth in Macau in 2013 and 13.7% for 2014. Sweet music to the ears of casino operators in the region is the outlook for strong consumer spending. Advancers: MPEL <font color=\"green\">+2.7%</font>, <a href=\"https://seekingalpha.com/symbol/LVS\" title=\"Las Vegas Sands Corp.\">LVS</a> <font color=\"green\">+2.4%</font>, <a href=\"https://seekingalpha.com/symbol/WYNN\" title=\"Wynn Resorts, Limited\">WYNN</a> <font color=\"green\">+1.7%</font>, <a href=\"https://seekingalpha.com/symbol/MGM\" title=\"MGM Resorts International\">MGM</a> <font color=\"green\">+1.2%</font>.</p><div class=\"tiny-share-widget\" data-id=\"907551\" data-linked=\"Casino stock show strength again with economic forecasts for Macau looking promising. The...\" data-tweet=\"$MLCO $MLCO $LVS - Casino stock show strength again with economic forecasts for Macau looking promising. The Economist sees 9.7% growth in Macau in 2013 and 13.7% for 2014. Sweet music to the ears of casino operators in the region is the outlook for str... https://seekingalpha.com/news/907551?source=tweet\" data-url=\"https://seekingalpha.com/news/907551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907471\" data-ts=\"1364220983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHKP\" target=\"_blank\">CHKP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lazard cuts Check Point (CHKP -1.9%) to Neutral; the firm says channel checks indicate share...</a></h4><a href=\"http://finance.yahoo.com/news/analysts-actions-bbry-chkp-cit-124000164.html;_ylt=Av9zXIXCYv.Gwg9zpjUHNi4CuodG;_ylu=X3oDMTQwNTd2ZjJzBG1pdANUb3AgU3RvcnkgQ29sbGVjdGlvbnMEcGtnAzkyYmY1Y2I5LTFhOTAtM2U3NS1hNTQ0LTJhZmU2YTQzMjM3ZQRwb3MDMTAEc2VjA3RvcF9zdG9yeQR2ZXIDYTc0ZDM2NzAtOTU0YS0xMWUyLWJlZmYtZjgwZTk5YmI3MTVj;_ylg=X3oDMTFlamZvM2ZlBGludGwDdXMEbGFuZwNlbi11cwRwc3RhaWQDBHBzdGNhdAMEcHQDc2VjdGlvbnM-;_ylv=3\" target=\"_blank\">Lazard cuts</a> Check Point (<a href='https://seekingalpha.com/symbol/CHKP' title='Check Point Software Technologies Ltd.'>CHKP</a> <font color='red'>-1.9%</font>) to Neutral; the firm says channel checks indicate share losses to Palo Alto Networks (<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a>) are growing. Palo Alto's next-gen firewalls are <a href=\"https://seekingalpha.com/currents/post/412571\" target=\"_blank\">causing headaches</a> for incumbent firewall vendors Check Point, Cisco, and Juniper thanks to their ability to support deeper content analysis on an integrated platform. The company <a href=\"http://www.bloomberg.com/news/2013-03-20/palo-alto-networks-clinches-ericsson-deal-as-customer-wins-mount.html\" target=\"_blank\">recently bragged</a> of an 85% win rate in deals it competes for.<div class=\"tiny-share-widget\" data-id=\"907471\" data-linked=\"Lazard cuts Check Point (CHKP -1.9%) to Neutral; the firm says channel checks indicate share...\" data-tweet=\"$CHKP $CHKP $PANW - Lazard cuts Check Point (CHKP -1.9%) to Neutral; the firm says channel checks indicate share losses to Palo Alto Networks (PANW) are growing. Palo Alto&#39;s next-gen firewalls are causing headaches for incumbent firewall vendors Check P... https://seekingalpha.com/news/907471?source=tweet\" data-url=\"https://seekingalpha.com/news/907471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907431\" data-ts=\"1364220547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFD\" target=\"_blank\">SFD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907431\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smithfield Foods (SFD +3.9%) trades higher after Goldman Sachs was hired to explore strategic...</a></h4><p>Smithfield Foods (<a href=\"https://seekingalpha.com/symbol/SFD\" title=\"Smithfield Foods Inc.\">SFD</a> <font color=\"green\">+3.9%</font>) trades higher after Goldman Sachs was hired to <a href=\"https://seekingalpha.com/currents/post/905951\" target=\"_blank\">explore</a> strategic options. A plan to split the the company into three separate business could <a href=\"http://www.bloomberg.com/news/2013-03-21/smithfield-seen-unlocking-23-gain-with-breakup-real-m-a.html\" target=\"_blank\">unlock value</a> of as much as $48-a-share, according to the rosiest of analyst estimates. Expect Goldman to explore selling Smithfield's hog farms and processing plants to an Asia-based company.</p><div class=\"tiny-share-widget\" data-id=\"907431\" data-linked=\"Smithfield Foods (SFD +3.9%) trades higher after Goldman Sachs was hired to explore strategic...\" data-tweet=\"$SFD - Smithfield Foods (SFD +3.9%) trades higher after Goldman Sachs was hired to explore strategic options. A plan to split the the company into three separate business could unlock value of as much as $48-a-share, according to the rosiest of analyst ... https://seekingalpha.com/news/907431?source=tweet\" data-url=\"https://seekingalpha.com/news/907431\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907241\" data-ts=\"1364219270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQU\" target=\"_blank\">EQU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alabama&amp;rsquo;s Montclair Energy makes a hostile $4/share takeover proposal to Equal Energy (EQU...</a></h4><p>Alabama\u2019s Montclair Energy makes a <a href=\"http://www.sacbee.com/2013/03/25/5290721/montclair-energy-llc-announces.html\" target=\"_blank\">hostile $4/share takeover proposal</a> to Equal Energy (<a href=\"https://seekingalpha.com/symbol/EQU\" title=\"Equal Energy Ltd.\">EQU</a> <font color=\"green\">+11.2%</font>), which is quickly rejected by EQU's board; it says it will consider requisitioning a special meeting of EQU\u2019s shareholders.</p><div class=\"tiny-share-widget\" data-id=\"907241\" data-linked=\"Alabama\u2019s Montclair Energy makes a hostile $4/share takeover proposal to Equal Energy (EQU...\" data-tweet=\"$EQU - Alabama\u2019s Montclair Energy makes a hostile $4/share takeover proposal to Equal Energy (EQU +11.2%), which is quickly rejected by EQU&#39;s board; it says it will consider requisitioning a special meeting of EQU\u2019s shareholders. https://seekingalpha.com/news/907241?source=tweet\" data-url=\"https://seekingalpha.com/news/907241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907111\" data-ts=\"1364217499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Back to the future: The return of Richard Schulze to Best Buy (NYSE:BBY) as Chairman Emeritus...</a></h4><p>Back to the future: The <a href=\"https://seekingalpha.com/currents/post/907011\" target=\"_blank\">return</a> of Richard Schulze to Best Buy (NYSE:<a href=\"https://seekingalpha.com/symbol/BBY\" title=\"Best Buy Co.\">BBY</a>) as Chairman Emeritus along with two of his nominees to the board is a <a href=\"https://twitter.com/LaMonicaBuzz/status/316167799275933696\" target=\"_blank\">good indication</a> the founder will hold on to the large stake in the company he owns and will back a turnaround plan. If CEO Joly and Schulze are on the same page, analysts think the chances for a Best Buy revival look more promising. Shares of BBY <font color=\"green\">+0.7%</font> premarket to $22.92, marking their highest trading level in ten months.</p><div class=\"tiny-share-widget\" data-id=\"907111\" data-linked=\"Back to the future: The return of Richard Schulze to Best Buy (NYSE:BBY) as Chairman Emeritus...\" data-tweet=\"$BBY - Back to the future: The return of Richard Schulze to Best Buy (NYSE:BBY) as Chairman Emeritus along with two of his nominees to the board is a good indication the founder will hold on to the large stake in the company he owns and will back a turn... https://seekingalpha.com/news/907111?source=tweet\" data-url=\"https://seekingalpha.com/news/907111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907101\" data-ts=\"1364217239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VOD\" target=\"_blank\">VOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vodafone (NASDAQ:VOD) +2.6% after The Sunday Times reports the carrier is &quot;leaning towards...</a></h4><p>Vodafone (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VOD\" title=\"Vodafone Group Plc\">VOD</a>) <font color=\"green\">+2.6%</font> after <a href=\"http://www.thesundaytimes.co.uk/sto/business/Companies/article1234738.ece\" target=\"_blank\"><em>The Sunday Times</em> reports</a> the carrier is \"leaning towards making a clean break\" with Verizon (NYSE:<a href=\"https://seekingalpha.com/symbol/VZ\" title=\"Verizon Communications\">VZ</a>), and that a Verizon Wireless deal could happen by summer. Talks are said to be \"fluid and free-form,\" with Verizon shareholders standing in the way of a full-blown merger out of concerns about Vodafone's European ops. The paper also claims Vodafone execs have privately told investors they can \"mitigate or eliminate\" Vodafone's capital gains tax bill. (<a href=\"https://seekingalpha.com/currents/search?query=vod%20vz\" target=\"_blank\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"907101\" data-linked=\"Vodafone (NASDAQ:VOD) +2.6% after The Sunday Times reports the carrier is &quot;leaning towards...\" data-tweet=\"$VOD $VOD $VZ - Vodafone (NASDAQ:VOD) +2.6% after The Sunday Times reports the carrier is &quot;leaning towards making a clean break&quot; with Verizon (NYSE:VZ), and that a Verizon Wireless deal could happen by summer. Talks are said to be &quot;fluid and free-form,&quot;... https://seekingalpha.com/news/907101?source=tweet\" data-url=\"https://seekingalpha.com/news/907101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907091\" data-ts=\"1364217051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAZA\" target=\"_blank\">ZAZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: OTC:ZAZA +21%. ARWR +14%. APOL +9%. TSRX +5%.&amp;nbsp; Losers: IDIX -10%. OTT...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/ZAZA\" title=\"ZaZa Energy Corp\">OTC:ZAZA</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/ARWR\" title=\"Arrowhead Pharmaceuticals\">ARWR</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/APOL\" title=\"Apollo Education Group, Inc.\">APOL</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/TSRX\" title=\"\">TSRX</a> <font color=\"green\">+5%</font>.  <b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/IDIX\" title=\"Idenix Pharmaceuticals, Inc.\">IDIX</a> <font color=\"red\">-10%</font>. OTT <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/UTHR\" title=\"United Therapeutics Corporation\">UTHR</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/PGTI\" title=\"PGT Innovations, Inc.\">PGTI</a> <font color=\"red\">-6%</font>. <div class=\"tiny-share-widget\" data-id=\"907091\" data-linked=\"Premarket gainers: OTC:ZAZA +21%. ARWR +14%. APOL +9%. TSRX +5%.  Losers: IDIX -10%. OTT -10%....\" data-tweet=\"$ZAZA $ZAZA $ARWR - Premarket gainers: OTC:ZAZA +21%. ARWR +14%. APOL +9%. TSRX +5%.  Losers: IDIX -10%. OTT -10%. UTHR -7%. PGTI -6%.  https://seekingalpha.com/news/907091?source=tweet\" data-url=\"https://seekingalpha.com/news/907091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"907071\" data-ts=\"1364216993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KWK\" target=\"_blank\">KWK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/907071\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quicksilver Resources (NYSE:KWK) +3.9% premarket after saying late Friday its net loss for Q4...</a></h4><p>Quicksilver Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/KWK\" title=\"Quicksilver Resources Inc.\">KWK</a>) <font color=\"green\">+3.9%</font> premarket after saying late Friday its net loss for Q4 and full-year 2012 were smaller than it previously reported, restating its results to correct errors related to the accounting for derivatives. Final Q4 net loss was $548M ($3.22/share) and $2.4B ($13.83/share) for full-year 2012 vs. previous report of net losses of $1.1B for Q4 and $2.5B for 2012.</p><div class=\"tiny-share-widget\" data-id=\"907071\" data-linked=\"Quicksilver Resources (NYSE:KWK) +3.9% premarket after saying late Friday its net loss for Q4...\" data-tweet=\"$KWK - Quicksilver Resources (NYSE:KWK) +3.9% premarket after saying late Friday its net loss for Q4 and full-year 2012 were smaller than it previously reported, restating its results to correct errors related to the accounting for derivatives. Final Q4... https://seekingalpha.com/news/907071?source=tweet\" data-url=\"https://seekingalpha.com/news/907071\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"906991\" data-ts=\"1364215307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JASO\" target=\"_blank\">JASO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on JA&amp;nbsp;Solar&#39;s (NASDAQ:JASO) Q4 results: Gross margin swung to -4.6% vs. +0.5% a year...</a></h4><p>More on JA Solar's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a>) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/906561\">Q4 results</a>: Gross margin swung to -4.6% vs. +0.5% a year ago.    Expects to ship 410-430 MW of cells and panels in Q1, below Q4's 500 MW; expects to ship 1.7-1.9 GW during the full year, vs. 1.7 GW in 2012. Said it shut 300 MW of cell production capacity and 300 MW of panel capacity during Q4. JASO <font color=\"red\">-6.3%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"906991\" data-linked=\"More on JA Solar&#39;s (NASDAQ:JASO) Q4 results: Gross margin swung to -4.6% vs. +0.5% a year ago....\" data-tweet=\"$JASO - More on JA Solar&#39;s (NASDAQ:JASO) Q4 results: Gross margin swung to -4.6% vs. +0.5% a year ago. Expects to ship 410-430 MW of cells and panels in Q1, below Q4&#39;s 500 MW; expects to ship 1.7-1.9 GW during the full year, vs. 1.7 GW in 2012. Said it ... https://seekingalpha.com/news/906991?source=tweet\" data-url=\"https://seekingalpha.com/news/906991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"906891\" data-ts=\"1364213837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The parade of analyst adoration for Best Buy (NYSE:BBY) continues with Barclays raising its...</a></h4><p>The parade of <a href=\"https://seekingalpha.com/currents/post/899371\" target=\"_blank\">analyst adoration</a> for Best Buy (NYSE:<a href=\"https://seekingalpha.com/symbol/BBY\" title=\"Best Buy Co.\">BBY</a>) continues with Barclays raising its price target on shares to $28 from $20. Many of the investment firm upgrades have been tied to confidence in CEO Hubert Joly's ability to streamline the big box retailer. BBY <font color=\"green\">+1.1%</font> premarket to $23.00.</p><div class=\"tiny-share-widget\" data-id=\"906891\" data-linked=\"The parade of analyst adoration for Best Buy (NYSE:BBY) continues with Barclays raising its...\" data-tweet=\"$BBY - The parade of analyst adoration for Best Buy (NYSE:BBY) continues with Barclays raising its price target on shares to $28 from $20. Many of the investment firm upgrades have been tied to confidence in CEO Hubert Joly&#39;s ability to streamline the b... https://seekingalpha.com/news/906891?source=tweet\" data-url=\"https://seekingalpha.com/news/906891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"906871\" data-ts=\"1364213569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAZA\" target=\"_blank\">ZAZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ZaZa Energy (OTC:ZAZA) +21.2% premarket after agreeing to sell its Eagle Ford Moulton assets in...</a></h4><p>ZaZa Energy (<a href=\"https://seekingalpha.com/symbol/ZAZA\" title=\"ZaZa Energy Corp\">OTC:ZAZA</a>) <font color=\"green\">+21.2%</font> premarket after agreeing to sell its Eagle Ford Moulton assets in Texas, including seven producing wells, in two separate transactions for a combined price of $52.5M, and signs a joint exploration and development agreement \"with one of the largest independent crude oil and natural gas companies\" in the U.S. to develop assets elsewhere in Texas.</p><div class=\"tiny-share-widget\" data-id=\"906871\" data-linked=\"ZaZa Energy (OTC:ZAZA) +21.2% premarket after agreeing to sell its Eagle Ford Moulton assets in...\" data-tweet=\"$ZAZA - ZaZa Energy (OTC:ZAZA) +21.2% premarket after agreeing to sell its Eagle Ford Moulton assets in Texas, including seven producing wells, in two separate transactions for a combined price of $52.5M, and signs a joint exploration and development ag... https://seekingalpha.com/news/906871?source=tweet\" data-url=\"https://seekingalpha.com/news/906871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"906821\" data-ts=\"1364212925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry (BBRY) slides&amp;nbsp;another 6.2%&amp;nbsp;premarket, with Goldman&amp;nbsp;cutting to...</a></h4><p>BlackBerry (BBRY) slides <font color=\"red\">another 6.2%</font> premarket, with Goldman <a href=\"http://www.streetinsider.com/Downgrades/Goldman+Calls+BlackBerry+%28BBRY%29+Z10+Launch+Disappointing%3B+Cuts+to+Neutral/8207832.html\" target=\"_blank\">cutting to Hold</a> amid the soft AT&amp;T launch. Citigroup reiterates its $6 price target, saying <a href=\"https://twitter.com/thenotablecalls/status/316144347357798400\" target=\"_blank\">internal checks</a> show sales of the Z10 have dramatically slowed and carriers have shifted promotions to other products. \"Shockingly low support by AT&amp;T with extremely limited signage ... most AT&amp;T employees (have) not even been trained on the device.\"</p><div class=\"tiny-share-widget\" data-id=\"906821\" data-linked=\"BlackBerry (BBRY) slides another 6.2% premarket, with Goldman cutting to Hold amid the soft...\" data-tweet=\"$BB - BlackBerry (BBRY) slides another 6.2% premarket, with Goldman cutting to Hold amid the soft AT&amp;T launch. Citigroup reiterates its $6 price target, saying internal checks show sales of the Z10 have dramatically slowed and carriers have shifted prom... https://seekingalpha.com/news/906821?source=tweet\" data-url=\"https://seekingalpha.com/news/906821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"906661\" data-ts=\"1364209942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DELL-OLD\" target=\"_blank\">DELL-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906661\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dell (DELL-OLD) confirms it received separate acquisition proposals from Blackstone (NYSE:BX)...</a></h4><p>Dell (<a href=\"https://seekingalpha.com/symbol/DELL-OLD\" title=\"Dell Inc.\">DELL-OLD</a>) confirms it received separate acquisition proposals from Blackstone (NYSE:<a href=\"https://seekingalpha.com/symbol/BX\" title=\"The Blackstone Group L.P.\">BX</a>) and Carl Icahn. The company says it will work for the best possible outcome for Dell shareholders without giving a specific timetable. DELL <font color=\"green\">+2.6%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"906661\" data-linked=\"Dell (DELL-OLD) confirms it received separate acquisition proposals from Blackstone (NYSE:BX)...\" data-tweet=\"$DELL-OLD $DELL-OLD $BX - Dell (DELL-OLD) confirms it received separate acquisition proposals from Blackstone (NYSE:BX) and Carl Icahn. The company says it will work for the best possible outcome for Dell shareholders without giving a specific timetable... https://seekingalpha.com/news/906661?source=tweet\" data-url=\"https://seekingalpha.com/news/906661\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"906541\" data-ts=\"1364206263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTHR\" target=\"_blank\">UTHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906541\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The FDA has again rejected United Therapeutics&#39; (NASDAQ:UTHR) Treprostinil oral treatment for...</a></h4><p>The FDA has again rejected United Therapeutics' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/UTHR\" title=\"United Therapeutics Corporation\">UTHR</a>) Treprostinil oral treatment for treating for high blood pressure. United Therapeutics intends to immediately request an \"end of review\" meeting with the FDA to discuss the rejection. Shares <font color=\"red\">-6.3%</font> premarket. (<a href=\"https://seekingalpha.com/currents/search?query=Treprostinil\" target=\"_blank\">previous</a>) (PR)</p><div class=\"tiny-share-widget\" data-id=\"906541\" data-linked=\"The FDA has again rejected United Therapeutics&#39; (NASDAQ:UTHR) Treprostinil oral treatment for...\" data-tweet=\"$UTHR - The FDA has again rejected United Therapeutics&#39; (NASDAQ:UTHR) Treprostinil oral treatment for treating for high blood pressure. United Therapeutics intends to immediately request an &quot;end of review&quot; meeting with the FDA to discuss the rejection. ... https://seekingalpha.com/news/906541?source=tweet\" data-url=\"https://seekingalpha.com/news/906541\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"906481\" data-ts=\"1364202726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Like in Asia, European shares rise, as do U.S. futures, following news of Cyprus&#39;s &amp;euro;10B...</a></h4><p>Like in Asia, <a href=\"http://www.bloomberg.com/news/2013-03-25/stocks-euro-gain-as-cyprus-nears-bailout-deal-gold-bonds-fall.html\" target=\"_blank\">European shares rise,</a> as do U.S. futures, following news of Cyprus's <a href=\"https://seekingalpha.com/currents/search?query=cyprus\" target=\"_blank\">\u20ac10B bailout deal</a>, with the EU Stoxx 50 <font color=\"green\">+1.3%</font>, London <font color=\"green\">+0.6%</font>, Paris <font color=\"green\">+1.4%</font>, Frankfurt <font color=\"green\">+1.1%</font>, Milan <font color=\"green\">+0.4%</font> and Madrid <font color=\"green\">+0.8%</font>. S&amp;P futures <font color=\"green\">+0.35%</font>, oil <font color=\"green\">+0.4%</font>, gold <font color=\"red\">-0.1%</font>.</p><div class=\"tiny-share-widget\" data-id=\"906481\" data-linked=\"Like in Asia, European shares rise, as do U.S. futures, following news of Cyprus&#39;s \u20ac10B bailout...\" data-tweet=\"$SPY $ULE $EUO - Like in Asia, European shares rise, as do U.S. futures, following news of Cyprus&#39;s \u20ac10B bailout deal, with the EU Stoxx 50 +1.3%, London +0.6%, Paris +1.4%, Frankfurt +1.1%, Milan +0.4% and Madrid +0.8%. S&amp;P futures +0.35%, oil +0.4%, g... https://seekingalpha.com/news/906481?source=tweet\" data-url=\"https://seekingalpha.com/news/906481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"906411\" data-ts=\"1364197255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906411\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A week&#39;s a long time in the financial markets. Last Monday, a plan to hit depositors in Cyprus...</a></h4><p>A week's a long time in the financial markets. Last Monday, a plan to hit depositors in Cyprus sent global shares and the euro tumbling. Today, a <a href=\"https://seekingalpha.com/currents/search?query=cyprus\" target=\"_blank\">plan to hit depositors</a> in Cyprus has sent <a href=\"http://www.marketwatch.com/story/asia-stocks-rally-on-reported-cyprus-deal-2013-03-24\" target=\"_blank\">most Asian bourses</a> and the euro higher. Japan <font color=\"green\">+1.7%</font>, Hong Kong <font color=\"green\">+0.6%</font>, China <font color=\"red\">-0.1%</font>, India <font color=\"green\">+0.6%</font>. Euro <font color=\"green\">+0.1%</font> vs the dollar.</p><div class=\"tiny-share-widget\" data-id=\"906411\" data-linked=\"A week&#39;s a long time in the financial markets. Last Monday, a plan to hit depositors in Cyprus...\" data-tweet=\"A week&#39;s a long time in the financial markets. Last Monday, a plan to hit depositors in Cyprus sent global shares and the euro tumbling. Today, a plan to hit depositors in Cyprus has sent most Asian bourses and the euro higher. Japan +1.7%, Hong Kong +0... https://seekingalpha.com/news/906411?source=tweet\" data-url=\"https://seekingalpha.com/news/906411\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 AM </div></div></li>","count":55,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}